Intel Capital

– Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced a $30m extension to its Series C funding round.
– The round was led by PFM Health Sciences with participation from ProAssurance, Harmonix, and existing investors such as the Relyens Group and IPF Partners.
– That round also included investments from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, and Surgical.AI.
– The funding will be used to continue developing its platform as well as advance new data solutions that support value-based care providers.

– GenXComm is an Austin TX-based provider of private networking solutions.
– Company raised $20M in Series B funding.
– The round was led by Motive Companies, with participation from Raine Next-Gen Communications, BMW iVentures, Intel Capital, Azure Capital and Bandgap Ventures.
– The company intends to use the funds to accelerate product development and commercial launch of their private 4G LTE and 5G network solutions.